Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

162.93 -1.32 (-0.80%)
Streaming Delayed Price Updated: 3:25 PM EDT, Mar 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,120,865
Open 163.97
Bid (Size) 162.93 (1)
Ask (Size) 162.94 (1)
Prev. Close 164.25
Today's Range 162.21 - 164.36
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.04%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm. 
Via Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results on disease activity and IgG reduction. 
Via Benzinga
Exposures Product Safety

Performance

YTD
+13.1%
+13.1%
1 Month
+5.1%
+5.1%
3 Month
+11.3%
+11.3%
6 Month
-2.5%
-2.5%
1 Year
+3.9%
+3.9%

More News

Read More
Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
Via Benzinga
Got $300? Buy These 3 Top Dividend Stocks and Never Look Back.
Via The Motley Fool
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Resilient Investing: 3 Stocks Built to Weather Market Volatility
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy
The S&P 500 Is in Correction Territory: 4 Surefire Stocks to Buy Right Now
Via The Motley Fool
Topics Stocks
Exposures US Equities
Coinbase, Apple And Robinhood Are Among Top Large-Cap Losers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
Via Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Kroger CEO Shake-Up
Via The Motley Fool
Cool, Calm, and Collected: 2 Dividend ETFs to Buy During the S&P 500 Sell-Off
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
Generate Passive Income From This Low-Cost Vanguard ETF That Is Crushing the S&P 500 in 2025
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?
Via The Motley Fool
Topics ETFs
Are High-Yield Dividend Stocks Best For Income-Focused Investors?
Via Talk Markets
Topics Stocks / Equities
How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket
Via Benzinga
2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger
Via The Motley Fool
Why Is Protagonist Therapeutics Stock Trading Higher On Monday?
Via Benzinga
Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out
Via Investor's Business Daily
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
3 Dividend Kings Shaking Off Market Woes
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
Via Benzinga
ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug
Via Benzinga
Broaden Your ETF Exposure With These 3 Overlooked Funds
Via MarketBeat
Topics ETFs Economy Government
Exposures Economy Interest Rates Political

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 162.93
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 03/19/25 03:25 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 428.29B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 428B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.